A. Wischnik

Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial

Jacobus Pfisterer, Catherine Shannon, Klaus Baumann et al. · The Lancet Oncology · 2020 · 157 citations

Medicine, Metronomic Therapy, Gynecology +8

Topotecan Weekly Versus Conventional 5-Day Schedule in Patients With Platinum-Resistant Ovarian Cancer: A Randomized Multicenter Phase II Trial of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group

Jalid Sehouli, Dirk Stengel, Philipp Harter et al. · Journal of Clinical Oncology · 2010 · 103 citations · Full text

The excretion of ketorolac tromethamine into breast milk after multiple oral dosing

A. Wischnik, S. M. Manth, Julia Lloyd et al. · European Journal of Clinical Pharmacology · 1989 · 79 citations

Breast Milk, Multiple Oral Dosing, Ketorolac Tromethamine +2

Tumor cell contamination of peripheral blood stem cell transplants and bone marrow in high-risk breast cancer patients

Ralf Schulze, Monika Schulze, A. Wischnik et al. · Bone Marrow Transplantation · 1997 · 57 citations

Breast Oncology, Transplantation, Marrow Transplantation +11

A multicentric observational trial of pegylated liposomal doxorubicin for metastatic breast cancer

Jens Huober, W. Fett, Arnd Nusch et al. · BMC Cancer · 2010 · 46 citations · Full text